BIOCON
Back to Balance Sheet
|
BIOCON Last 5 Year Total Non-Current Assets History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Non-Current Assets | ₹45,915 Cr | ₹42,253 Cr | ₹40,574 Cr | ₹39,408 Cr | ₹11,718 Cr |
What is the latest Total Non-Current Assets ratio of BIOCON ?
| Year | Total Non-Current Assets |
|---|---|
| Mar2026 | ₹45,915 Cr |
| Mar2025 | ₹42,253 Cr |
| Mar2024 | ₹40,574 Cr |
| Mar2023 | ₹39,408 Cr |
| Mar2022 | ₹11,718 Cr |
How is Total Non-Current Assets of BIOCON Trending?
| Years | Total Non-Current Assets | % Change | |
|---|---|---|---|
| Mar2026 | ₹45,915 Cr | 8.67 | |
| Mar2025 | ₹42,253 Cr | 4.14 | |
| Mar2024 | ₹40,574 Cr | 2.96 | |
| Mar2023 | ₹39,408 Cr | 236.29 | |
| Mar2022 | ₹11,718 Cr | - | |
Compare Total Non-Current Assets of peers of BIOCON
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BIOCON | ₹67,045.9 Cr | 0.3% | -3.3% | 16.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹460,696.0 Cr | 0.5% | -4% | 15.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹246,063.0 Cr | 9.1% | 18.2% | 47.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹191,515.0 Cr | 3.6% | 3.4% | 36.4% | Stock Analytics | |
| CIPLA | ₹114,554.0 Cr | -1.2% | -3.3% | -10.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹98,308.6 Cr | -1.4% | 2.9% | -8% | Stock Analytics | |
BIOCON Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BIOCON | 0.3% |
-3.3% |
16.3% |
| SENSEX | -0.4% |
-0.5% |
-5.8% |
You may also like the below Video Courses